Sera Prognostics, Inc. - Class A Common Stock (NQ:SERA)

2.090 +0.050 (+2.45%)

Delayed Quote Updated: 3:58 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Sera Prognostics, Inc. - Class A Common Stock

< Previous 1 2 3 4 Next >

Why Catalyst Biosciences Shares Are Trading Higher By 105%; Here Are 20 Stocks Moving Premarket ↗

February 28, 2023

Gainers Catalyst Biosciences Inc (NASDAQ: CBIO) rose 105% to $0.49 in pre-market trading. South Korea's GC Biopharma said it has signed an asset purchase agreement with Catalyst Biosciences to acquire...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

February 16, 2023

Via Benzinga

Why Axcella Health Shares Are Trading Higher By 54%; Here Are 20 Stocks Moving Premarket ↗

February 16, 2023

Gainers Axcella Health Inc. (NASDAQ: AXLA) shares rose 54.1% to $0.9290 in pre-market trading after the company announced FDA clearance of its IND application to initiate a phase 2b/3 trial in the U.S....

Via Benzinga

Sera Prognostics's Return On Capital Employed Overview ↗

December 14, 2022

Via Benzinga

Recap: Sera Prognostics Q2 Earnings ↗

August 10, 2022

Sera Prognostics (NASDAQ:SERA) reported its Q2 earnings results on Wednesday, August 10, 2022 at 04:00 PM. Here's what investors need to know about the announcement.

Via Benzinga

Sera Prognostics Earnings Outlook ↗

August 09, 2022

Sera Prognostics (NASDAQ:SERA) is set to give its latest quarterly earnings report on Wednesday, 2022-08-10. Here's what investors need to know before the announcement.

Via Benzinga

Nasdaq Surges 90 Points; Credo Technology Group Shares Slide ↗

February 15, 2023

U.S. stocks turned mostly higher toward the end of trading, with the Nasdaq Composite gaining around 90 points on Wednesday. The Dow traded down 0.01% to 34,085.88 while the NASDAQ rose 0.76% to...

Via Benzinga

Why Sabre Are Trading Lower By 19%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

February 15, 2023

Gainers Sera Prognostics, Inc. (NASDAQ: SERA) shares surged 63.4% to $2.11 after the company announced top-line data from the AVERT PRETERM TRIAL.

Via Benzinga

Gold Down 1%; Roblox Shares Spike Higher ↗

February 15, 2023

U.S. stocks traded mostly lower midway through trading, with the Dow Jones dropping over 100 points on Wednesday. The Dow traded down 0.34% to 33,974.46 while the NASDAQ rose 0.22% to 11,986.30. The...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

February 15, 2023

Via Benzinga

Why Are Sera Prognostics Shares Trading Higher Today? ↗

February 15, 2023

Sera Prognostics Inc (NASDAQ: SERA) announced top-line results from the AVERT PRETERM TRIAL.

Via Benzinga

Sera Prognostics (NASDAQ: SERA) Releases Positive Data from AVERT PRETERM Trial

February 15, 2023

Sera Prognostics, Inc. (NASDAQ: SERA) is engaged as a health diagnostics company, which is focused around developing treatments and solutions

Via Spotlight Growth

12 Health Care Stocks Moving In Monday's Intraday Session ↗

July 18, 2022

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

July 13, 2022

Via Benzinga

Why Allena Pharmaceuticals Tumbled Over 30%; Here Are 85 Biggest Movers From Yesterday ↗

September 07, 2022

Gainers Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH) shares jumped 91.3% to close at $28.50 on Tuesday amid post-IPO volatility.

Via Benzinga

Why HyreCar Is Trading Higher By 60%, Here Are 63 Stocks Moving In Tuesday's Mid-Day Session ↗

September 06, 2022

Gainers HyreCar Inc. (NASDAQ: HYRE) jumped 60% to $1.2680 after the company announced it has received a $100 million revolving line of credit from a premier global investment bank and Medalist...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

June 28, 2022

Gainers

Via Benzinga

InflaRx Climbs More Than 40%, Here's 58 Biggest Movers From Yesterday ↗

June 29, 2022

Gainers Agile Therapeutics, Inc. (NASDAQ: AGRX) shares climbed 89.8% to close at $2.41 on Tuesday. Agile Therapeutics shares climbed over 10% on Monday amid the Supreme Court overturning Roe V Wade.

Via Benzinga

Why Is Ceragon Networks Surging By 19%? 41 Stocks Moving In Tuesday's Mid-Day Session ↗

June 28, 2022

Gainers Agile Therapeutics, Inc. (NASDAQ: AGRX) jumped 88.9% to $2.3986. Agile Therapeutics shares climbed over 10% on Monday amid the Supreme Court overturning Roe V Wade.

Via Benzinga

This Healthcare Stock Jumps Around 188%, Here's 83 Biggest Movers From Yesterday ↗

June 28, 2022

Gainers Evofem Biosciences, Inc. (NASDAQ: EVFM) shares jumped 187.7% to close at $1.07 on Monday amid the Supreme Court overturning Roe V Wade.

Via Benzinga

Carnival Surges Over 12%, Here's 75 Biggest Movers From Friday ↗

June 27, 2022

Gainers USA Truck, Inc. (NASDAQ: USAK) shares climbed 112.6% to close at $31.00 on Friday. DB Schenker and USA Truck announced plans to combine and create premier North American transportation...

Via Benzinga

Sera Prognostics Earnings Perspective: Return On Capital Employed ↗

June 13, 2022

According to data from Benzinga Pro, during Q1, Sera Prognostics's (NASDAQ:SERA) reported sales totaled $38.00 thousand. Despite a 2.21% increase in earnings, the company posted a loss of $12.21...

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

June 02, 2022

During the Thursday's session, 100 stocks hit new 52-week lows.

Via Benzinga

Looking Into Sera Prognostics's Return On Capital Employed ↗

March 30, 2022

Benzinga Pro data, Sera Prognostics (NASDAQ:SERA) reported Q4 sales of $26.00 thousand. Earnings fell to a loss of $12.48 million, resulting in a 26.63% decrease from last quarter.

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

May 17, 2022

On Tuesday, 123 stocks made new 52-week lows.

Via Benzinga

Earnings Scheduled For May 10, 2022 ↗

May 10, 2022

Companies Reporting Before The Bell • The Middleby (NASDAQ:MIDD) is expected to report quarterly earnings at $2.10 per share on revenue of $935.99 million.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For March 30, 2022 ↗

March 30, 2022

Upgrades

Via Benzinga

10 Biggest Price Target Changes For Wednesday ↗

March 30, 2022

Morgan Stanley raised the price target on IGM Biosciences, Inc. (NASDAQ: IGMS) from $25 to $30. IGM Biosciences shares fell 4% to $28.32 in pre-market trading.

Via Benzinga

Earnings Scheduled For March 29, 2022 ↗

March 29, 2022

Companies Reporting Before The Bell • 36KR Holdings (NASDAQ:KRKR) is projected to report quarterly loss at $0.02 per share on revenue of $15.62 million.

Via Benzinga

75 Biggest Movers From Yesterday ↗

March 22, 2022

Gainers NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) shares jumped 299.4% to close at $6.23 on Monday as the company received clearance from the FDA to initiate a pharmacokinetic...

Via Benzinga

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.